Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
- Predicts the onset of Alzheimer’s Disease (AD) using deep learning-based Splice-AI
- When foams collapse (and when they don’t)
- Oahu marine protected areas offer limited protection of coral reef herbivorous fishes
- Picture books can boost physical activity for youth with autism
- Atherosclerosis can accelerate the development of clonal hematopoiesis, study finds